Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetylpyridinium SCHEMBL5455822 | 1.00 | CHRM2 (0.53) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Cetylpyridinium SCHEMBL2369770 | 0.90 | MAPT (0.43) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Cetylpyridinium SCHEMBL2369768 | 0.81 | KMT2A (0.43) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Cetylpyridinium SCHEMBL9738452 | 0.80 | ACHE (0.77) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Cetylpyridinium SCHEMBL9738456 | 0.80 | ACHE (0.77) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Cinnamic Acid SCHEMBL28417502 | 0.79 | EGFR (0.41) | SMN1; SMN2EGFRHTTMAPTHDAC3 | |
| Cinnamic Acid SCHEMBL28417500 | 0.79 | EGFR (0.41) | SMN1; SMN2EGFRHTTMAPTHDAC3 | |
| Tetrabuthylammonium SCHEMBL5992066 | 0.79 | EGFR (0.54) | ACHEKMT2ASMN1; SMN2EGFRLMNA | |
| Tetrabuthylammonium SCHEMBL5992067 | 0.79 | EGFR (0.54) | ACHEKMT2ASMN1; SMN2EGFRLMNA | |
| Cetylpyridinium SCHEMBL1686038 | 0.79 | CHRM2 (0.61) | CHRM2ADRA2AADORA3CHRM1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | CHRM2 2670/4885ADRA2A 1965/4885ADORA3 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.